1-16 of 16
Brad S. Kahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium

Jonathan R Day, Melissa C. Larson, Urshila Durani, Jean L Koff, Yucai Wang, Thomas M. Habermann, Izidore S Lossos, Loretta J. Nastoupil, Christopher S Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B Cohen, Brad S. Kahl, Jia Ruan, Richard Burack, Jonathan W. Friedberg, James R Cerhan, Christopher R. Flowers, Brian L Link, Matthew J. Maurer, Carla Casulo
Journal: Blood Advances
Blood Adv bloodadvances.2024014053.
https://doi.org/10.1182/bloodadvances.2024014053
Published: 2024
Includes: Supplemental data
Journal Articles

Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL

Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M. Reagan, Umar Farooq, Jason T. Romancik, Timothy J. McDonnell, Shaun M. Riska, lzidore S. Lossos, Brad S. Kahl, Peter Martin, Thomas E. Witzig, James R. Cerhan, Christopher R. Flowers, Grzegorz S. Nowakowski, Matthew J. Maurer
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4414–4422.
https://doi.org/10.1182/bloodadvances.2024012838
Published: 2024
Includes: Supplemental data
Journal Articles

Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma

Clinical Trials & Observations
Cody A. Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A. Russler-Germain, Felix Frenkel, Erica K. Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L. Skidmore, Marcus P. Watkins, Thomas B. Mooney, Jason R. Walker, Kilannin Krysiak, Felicia Gomez, Catrina C. Fronick, Robert S. Fulton, Robert D. Schreiber, Neha Mehta-Shah, Amanda F. Cashen, Brad S. Kahl, Ravshan Ataullakhanov, Nancy L. Bartlett, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4035–4049.
https://doi.org/10.1182/bloodadvances.2022007792
Published: 2024
Includes: Supplemental data
Journal Articles

Defining primary refractory large B-cell lymphoma

Allison M. Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew J. Maurer, Amy Ayers, Brad S. Kahl, Peter Martin, Jonathon B. Cohen, Carla Casulo, Izidore S. Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M. Habermann, Thomas E. Witzig, Christopher R. Flowers, James R. Cerhan, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3402–3415.
https://doi.org/10.1182/bloodadvances.2024012760
Published: 2024
Includes: Supplemental data
Journal Articles

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Clinical Trials & Observations
Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina Wagner-Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3189–3199.
https://doi.org/10.1182/bloodadvances.2023011657
Published: 2024
Includes: Supplemental data
Journal Articles

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

David A. Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F. Cashen, Neha Mehta-Shah, Brad S. Kahl, Nancy L. Bartlett, Juan P. Alderuccio, Izidore S. Lossos, Sarah L. Ondrejka, Eric D. Hsi, Peter Martin, John P. Leonard, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5524–5539.
https://doi.org/10.1182/bloodadvances.2023010779
Published: 2023
Includes: Supplemental data
Journal Articles

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Clinical Trials & Observations
Rahul Lakhotia, Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani, Andrea N. Lucas, Seth M. Steinberg, Jonathan W. Friedberg, Brad S. Kahl, Richard F. Little, Nancy L. Bartlett, Ariela Noy, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5320–5324.
https://doi.org/10.1182/bloodadvances.2023010223
Published: 2023
Journal Articles

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Yazeed Sawalha, Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, I. Brian Greenwell, Brian T. Hess, Krista M. Isaac, Craig A. Portell, Alex Mejia Garcia, Scott Goldsmith, Natalie S. Grover, Peter A. Riedell, Reem Karmali, Madelyn Burkart, Michael Buege, Othman Akhtar, Pallawi Torka, Anita Kumar, Brian T. Hill, Brad S. Kahl, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2983–2993.
https://doi.org/10.1182/bloodadvances.2022008916
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study

Clinical Trials & Observations
Juan P. Alderuccio, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Matthew A. Lunning, Brian T. Hess, Pier L. Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S. Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F. Caimi
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4736–4739.
https://doi.org/10.1182/bloodadvances.2022007782
Published: 2022
Journal Articles

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Clinical Trials & Observations
R. Andrew Harkins, Sharvil P. Patel, Michelle J. Lee, Jeffrey M. Switchenko, Stephen M. Ansell, Nancy L. Bartlett, Kristie A. Blum, Amanda F. Cashen, Carla Casulo, Jonathan W. Friedberg, Patrick B. Johnston, Brad S. Kahl, John P. Leonard, Brian K. Link, Izidore S. Lossos, Peter Martin, Matt J. Maurer, Neha Mehta-Shah, Patrick M. Reagan, Jason R. Westin, Jean L. Koff, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2745–2756.
https://doi.org/10.1182/bloodadvances.2021006504
Published: 2022
Includes: Supplemental data
Journal Articles

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

Clinical Trials & Observations
Juan Pablo Alderuccio, Luca Arcaini, Marcus P. Watkins, Anne W. Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B. Alpert, Adam J. Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J. Castillo, Lisa Argnani, Timothy J. Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M. Reis, Deukwoo Kwon, Jonathan S. Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian K. Link, Constantine N. Logothetis, Alex F. Herrera, Jonathan W. Friedberg, Brad S. Kahl, Stefano Luminari, Pier Luigi Zinzani, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2035–2044.
https://doi.org/10.1182/bloodadvances.2021006844
Published: 2022
Journal Articles

Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma

Clinical Trials & Observations
Craig A. Portell, Nolan A. Wages, Brad S. Kahl, Lihua E. Budde, Robert W. Chen, Jonathon B. Cohen, Nikole E. Varhegyi, Gina R. Petroni, Michael E. Williams
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1490–1498.
https://doi.org/10.1182/bloodadvances.2021005357
Published: 2022
Includes: Supplemental data
Journal Articles

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Clinical Trials & Observations
David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami Maddocks, Michael Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Brian T. Hill, Yazeed Sawalha, Peter Martin, Edward Maldonado, Max Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S. Fenske, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Kristie A. Blum, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5179–5189.
https://doi.org/10.1182/bloodadvances.2021004765
Published: 2021
Includes: Supplemental data
Journal Articles

CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy

Bicky Thapa, Paolo F. Caimi, Kirit M. Ardeshna, Melhem Solh, Carmelo Carlo-Stella, Brad S. Kahl, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3850–3852.
https://doi.org/10.1182/bloodadvances.2020002587
Published: 2020
Journal Articles

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma

Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3132–3135.
https://doi.org/10.1182/bloodadvances.2019000526
Published: 2019